JPM24, Day 2: BioNTech warns of further COVID vaccine sales decline; Alnylam looks to become 'top-tier' biopharma player
JPM24, Day 2: BioNTech warns of further COVID vaccine sales decline; Alnylam looks to become 'top-tier' biopharma player
esagonowsky
Wed, 01/03/2024 - 14:40
